Atrial fibrillation in patients with liver disease: Recent advances

Keyphrases

• Atrial Fibrillation 100%
• Recent Advances 100%
• Patients with Liver Disease 100%
• Anticoagulation 60%
• Ischemic Stroke 20%
• Major Bleeding 20%
• Vitamin K Antagonists 20%
• Rate of Increase 20%
• International Normalized Ratio 20%
• Risk Factor Management 20%
• Thrombocytopenia 20%
• Hemorrhagic Disease 20%
• Pathophysiological Changes 20%
• Non-alcoholic Fatty Liver Disease (NAFLD) 20%
• Hepatic Impairment 20%
• Coagulation Cascade 20%
• Direct Oral Anticoagulants 20%
• Oral Anticoagulant Drugs 20%
• Drug Elimination 20%
• Elevation Change 20%
• Ischemic Stroke Risk 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Liver Disease 100%
• Brain Ischemia 40%
• Bleeding 20%
• Anticoagulant Agent 20%
• Elimination 20%
• Morbidity 20%
• Thrombocytopenia 20%
• Alcohol Liver Disease 20%
• Vitamin K Group 20%
• Direct Oral Anticoagulant 20%